Association between prior use of anti-diabetic medication and breast cancer stage at diagnosis
Journal
Expert Opinion on Drug Safety
Journal Volume
20
Journal Issue
2
Pages
235-243
Date Issued
2021
Author(s)
Abstract
Background: Knowledge regarding antidiabetic medication (ADM) use prior to breast cancer (BC) diagnosis remains limited. The objectives were to (1) evaluate if the prior use of ADM was associated with BC stage at diagnosis and (2) identify and compare pat
Subjects
Breast cancer; diabetes; medicare beneficiaries; stage at diagnosis
SDGs
Other Subjects
acarbose; albiglutide; alogliptin; antidiabetic agent; bromocriptine mesilate; canagliflozin; chlorpropamide; colesevelam; dapagliflozin; dulaglutide; empagliflozin; exendin 4; glibenclamide; glimepiride; glipizide; insulin; insulin degludec; insulin dete
Type
journal article